Showing results (341-350 of 8,520) with videos related to
Sort By:
Pageof 852
Alimentary Pharmacology & Therapeutics|January 31, 2006
Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitisO Palmieri, A Latiano, R Valvano, et al.Alimentary Pharmacology & Therapeutics|February 1, 1997
Review article: the dietary management of Crohn's diseaseT S King, J T Woolner, J O HunterAlimentary Pharmacology & Therapeutics|February 1, 1997
YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivoY Takinami, H Yuki, A Nishida, et al.Alimentary Pharmacology & Therapeutics|February 1, 1997
Prevention of heartburn relapse by low-dose famotidine: a test meal model for duration of symptom controlS G Mann, J Cottrell, A Murakami, et al.Alimentary Pharmacology & Therapeutics|February 1, 1997
Long-term effect of gluten restriction on bone mineral density of patients with coeliac diseaseJ C Bai, D Gonzalez, C Mautalen, et al.Alimentary Pharmacology & Therapeutics|February 1, 1997
Rectal steroids suppress bone formation in patients with colitisR J Robinson, S J Iqbal, R P Whitaker, et al.Alimentary Pharmacology & Therapeutics|February 1, 1996
A prospective study of the effectiveness of low dose omeprazole as initial therapy in Zollinger-Ellison syndromeB Termanini, F Gibril, C A Stewart, et al.Alimentary Pharmacology & Therapeutics|February 1, 1996
Symptomatology, quality of life and economic features of irritable bowel syndrome--the effect of hypnotherapyL A Houghton, D J Heyman, P J WhorwellAlimentary Pharmacology & Therapeutics|October 1, 1996
Low-dose famotidine and ranitidine as single post-prandial doses: a three-period placebo-controlled comparative trialT G Reilly, S Singh, J Cottrell, et al.Alimentary Pharmacology & Therapeutics|October 1, 1996
Influence of loperamide on lactose handling and oral-caecal transit timeA Szilagyi, R Salomon, E SeidmanPageof 852